Adelene Q. Perkins, President & CEO at INFINITY PHARMACEUTICALS, INC. (INFI), sold 20,000 shares at $16.00 ($320K) on 2015-03-16, disclosed to the SEC on 2015-03-17.
Scheduled sale ($320k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |